Stanford University: Inflammatory Bowel Diseases trials

The registry lists 11 Inflammatory Bowel Diseases studies with Stanford University as lead sponsor. 5 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized PatientsNot yet recruitingNCT07676136Not applicable
• Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial AssessmentNot yet recruitingNCT06066866
• Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics StudyRecruitingNCT05912387Early Phase 1
• Fermented Food-Supplemented Diet in Ulcerative ColitisRecruitingNCT04401605Not applicable
• The Influence of a Fasting Mimicking Diet on Ulcerative ColitisRecruitingNCT03615690Not applicable
• High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)CompletedNCT05587673Phase 1
• Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel DiseaseCompletedNCT04828031Phase 1
• Yoga for Youth With IBD: a Pilot Feasibility StudyCompletedNCT04757935Not applicable
• Effects of an Intermittent Reduced Calorie Diet on Crohn's DiseaseCompletedNCT04147585Not applicable
• Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic IllnessCompletedNCT02453880Not applicable
• Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy ControlsCompletedNCT01860963Not applicable